Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity.
Chun Jing Wang, Lina Petersone, Natalie M Edner, Frank Heuts, Vitalijs Ovcinnikovs, Elisavet Ntavli, Alexandros Kogimtzis, Astrid Fabri, Yassin Elfaki, Luke P Houghton, Ralf J Hosse, David A Schubert, Andreas P Frei, Ellen M Ross, Lucy S K Walker
Author Information
- Chun Jing Wang: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK.
- Lina Petersone: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK. ORCID
- Natalie M Edner: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK. ORCID
- Frank Heuts: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK.
- Vitalijs Ovcinnikovs: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK.
- Elisavet Ntavli: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK.
- Alexandros Kogimtzis: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK.
- Astrid Fabri: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK.
- Yassin Elfaki: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK. ORCID
- Luke P Houghton: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK.
- Ralf J Hosse: Roche Innovation Center Zurich, Roche Pharma Research & Early Development (pRED), Schlieren, Switzerland.
- David A Schubert: Roche Innovation Center Basel, Roche Pharma Research & Early Development (pRED), Basel, Switzerland.
- Andreas P Frei: Roche Innovation Center Basel, Roche Pharma Research & Early Development (pRED), Basel, Switzerland. ORCID
- Ellen M Ross: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK. ORCID
- Lucy S K Walker: Institute of Immunity & Transplantation, Pears Building, University College London Division of Infection & Immunity, London, UK. lucy.walker@ucl.ac.uk. ORCID
No abstract text available.
